MXPA05006722A - Metodo para tratamiento de pacientes con exposicion a radiacion. - Google Patents

Metodo para tratamiento de pacientes con exposicion a radiacion.

Info

Publication number
MXPA05006722A
MXPA05006722A MXPA05006722A MXPA05006722A MXPA05006722A MX PA05006722 A MXPA05006722 A MX PA05006722A MX PA05006722 A MXPA05006722 A MX PA05006722A MX PA05006722 A MXPA05006722 A MX PA05006722A MX PA05006722 A MXPA05006722 A MX PA05006722A
Authority
MX
Mexico
Prior art keywords
radiation exposure
treating patients
patient
treating
thiol
Prior art date
Application number
MXPA05006722A
Other languages
English (en)
Inventor
H Hausheer Frederick
Original Assignee
Bionumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionumerik Pharmaceuticals Inc filed Critical Bionumerik Pharmaceuticals Inc
Publication of MXPA05006722A publication Critical patent/MXPA05006722A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a un metodo de tratamiento de un paciente que sufre de exposicion a radiacion, o de tratamiento profilactico de un paciente que va a sufrir terapia con radiacion. El metodo incluye administrar a un paciente en necesidad de tratamiento, una cantidad eficaz de un tiol o de un compuesto de disulfuro reducible segun la formula indicada en esta memoria.
MXPA05006722A 2001-10-26 2002-12-20 Metodo para tratamiento de pacientes con exposicion a radiacion. MXPA05006722A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/002,526 US7176192B2 (en) 2001-10-26 2001-10-26 Method for treating patients for radiation exposure
PCT/US2002/041665 WO2004058103A1 (en) 2001-10-26 2002-12-20 Method for treating patients for radiation exposure

Publications (1)

Publication Number Publication Date
MXPA05006722A true MXPA05006722A (es) 2005-10-05

Family

ID=32993245

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006722A MXPA05006722A (es) 2001-10-26 2002-12-20 Metodo para tratamiento de pacientes con exposicion a radiacion.

Country Status (8)

Country Link
US (1) US7176192B2 (es)
EP (1) EP1581149A4 (es)
JP (1) JP2006510714A (es)
CN (1) CN1735388A (es)
AU (1) AU2002360829B2 (es)
CA (1) CA2508243A1 (es)
MX (1) MXPA05006722A (es)
WO (1) WO2004058103A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8710095B2 (en) 2002-04-30 2014-04-29 Bionumerik Pharmaceuticals, Inc. Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
US20050256055A1 (en) * 2004-05-12 2005-11-17 Hausheer Frederick H Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
US20060063742A1 (en) * 2004-09-21 2006-03-23 Hausheer Frederick H Method of treatment for or protection against lymphedema
DK1991237T3 (en) * 2005-12-13 2015-04-27 Bionumerik Pharmaceuticals Inc Chemoprotective methods and compositions
AU2008352598B2 (en) * 2008-03-14 2012-06-07 Bionumerik Pharmaceuticals, Inc. Chemoprotective methods and compositions
US9937136B2 (en) 2013-11-17 2018-04-10 Rdd Pharma Ltd. Methods for treating radiation induced gastrointestinal tract injury
JP6271233B2 (ja) * 2013-11-29 2018-01-31 ローム・アンド・ハース電子材料株式会社 表面処理液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
GB9323399D0 (en) * 1993-11-12 1994-01-05 Univ Newcastle Ventures Ltd Pharmaceutical formulations
US5789000A (en) 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
US6160167A (en) * 1998-04-21 2000-12-12 Bionumerik Pharmaceuticals, Inc. Mercaptans and disulfides

Also Published As

Publication number Publication date
WO2004058103A1 (en) 2004-07-15
US20030092681A1 (en) 2003-05-15
AU2002360829A1 (en) 2004-07-22
EP1581149A4 (en) 2006-07-19
US7176192B2 (en) 2007-02-13
EP1581149A1 (en) 2005-10-05
AU2002360829B2 (en) 2008-09-18
CN1735388A (zh) 2006-02-15
JP2006510714A (ja) 2006-03-30
CA2508243A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
IL168365A (en) Use of a rasagaline with or without riluzole for preparing a medicament for treating amyotrophic lateral sclerosis
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
RS20050344A (en) Treatment for hemorrhagic shock
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
ATE358668T1 (de) Drogen zur behandlung maligner tumoren
BR0211932A (pt) Métodos e composições para administração oral de hormÈnio de paratireóide, pth
AP1749A (en) Method of treating of demyelinating diseases or conditions.
HK1080733A1 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
MXPA05006722A (es) Metodo para tratamiento de pacientes con exposicion a radiacion.
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
AU2003250190A1 (en) Combination of an aromatase inhibitor with a bisphosphonate
IL170519A (en) Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
MXPA03006412A (es) Metodos para administrar analogos de epotilona para tratamiento de cancer.
DE50108711D1 (de) Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
MXPA05006721A (es) Metodo para tratamiento de pacientes expuestos a agentes quimicos toxicos.
AU2002319223A1 (en) Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
BR0308911A (pt) Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto
MXPA03006359A (es) Metodo para tratamiento del cancer.
WO2003020221A3 (en) Method of treating cancerous disease

Legal Events

Date Code Title Description
FG Grant or registration